Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol PELI1 contributors: mct/npt/pgu - updated : 15-12-2017
HGNC name pellino E3 ubiquitin protein ligase 1
HGNC id 8827
DNA
TYPE functioning gene
STRUCTURE 51.82 kb     7 Exon(s)
10 Kb 5' upstream gene genomic sequence study
MAPPING cloned Y linked N status provisional
RNA
TRANSCRIPTS type messenger
identificationnb exonstypebpproduct
ProteinkDaAAspecific expressionYearPubmed
6 - 3780 - 418 - 2007 17675297
EXPRESSION
Type ubiquitous
   expressed in (based on citations)
organ(s)
SystemOrgan level 1Organ level 2Organ level 3Organ level 4LevelPubmedSpeciesStageRna symbol
blood / hematopoieticspleen    
Cardiovascularheart    
Lymphoid/Immunelymph node   highly
Nervousnerve   highly
Reproductivemale systemprostate   
Respiratoryrespiratory tracttrachea  highly
Urinarykidney    
tissue
SystemTissueTissue level 1Tissue level 2LevelPubmedSpeciesStageRna symbol
Lymphoid    
Muscularstriatumskeletal  
cell lineage
cell lines
fluid/secretion
at STAGE
PROTEIN
PHYSICAL PROPERTIES
STRUCTURE
motifs/domains
  • a partial zinc finger (C3HC4 type or RING finger)
  • a new RING-like motif
  • IRAK1-binding region consists largely of a previously unidentified forkhead-associated (FHA) domain, a well-characterized phosphothreonine-binding modules
  • a putative C terminal nuclear localization signal (NLS)
  • HOMOLOGY
    interspecies homolog to murine Peli1
    ortholog to Drosophila pli
    homolog to C.elegans f25b4.2
    Homologene
    FAMILY
  • Pellino family
  • CATEGORY adaptor
    SUBCELLULAR LOCALIZATION     intracellular
    intracellular,cytoplasm,cytosolic
    intracellular,nucleus
    text translocate in the nucleus
    basic FUNCTION
  • ubiquitin-protein isopeptide ligase, required for NF kappa B activation and IL-8 gene expression in response to IL-1, probably through its signal-dependent interaction with IRAK4, IRAK, TRAF6
  • implicated as evolutionary conserved scaffold proteins in TLR/IL-1R signaling leading to nuclear factor-kappaB and mitogen activated protein kinase-dependent gene expression
  • E3 ligases that can catalyze Lys(63)-linked polyubiquitination but also shows bidirectional signaling between the IRAK and Pellino families and highlights a novel function for IRAK kinase activity
  • RING E3 ubiquitin ligases involved in signaling events downstream of the Toll and interleukin-1 (IL1) receptors, key initiators of innate immune and inflammatory responses
  • induce IRAK1 polyubiquitination in a RING-dependent manner
  • PELI1 and PELI2 appear to function as positive regulators for NFKB activation
  • ubiquitin ligase needed for the transmission of TICAM1-dependent TLR signals
  • PELI1, PELI2, PELI3 are novel RING E3 ubiquitin ligases involved in IRAK1 polyubiquitination and degradation
  • PELI2, PELI3 (to a much lesser degree Pellino 1) carry the E3 ubiquitin ligase activity and promote polyubiquitination on IRAK1
  • Pellino1 is a novel component of the signal transduction network by which viral double-stranded RNA stimulates IFNB1 gene transcription
  • PELI1 interacts with the transcription factor DEAF1, and this interaction is independent of the E3 ligase activity of PELI1, but weakened by the phosphorylation of PELI1
  • PELI1, PELI2, PELI3 E3 ubiquitin ligases are emerging as critical mediators for a variety of immune signaling pathways, including those activated by Toll-like receptors, the T-cell receptor, and NOD2
  • nonredundant roles that PELI1, PELI2, PELI3 play in immune signaling are in part due to their divergent substrate specificities
  • promotes lymphomagenesis by deregulating BCL6 polyubiquitination
  • previously unrecognized role of PELI1 in extracellular matrix deposition and cardiac fibroblast activation in response to mechanical stress
  • is an innate immune regulator in the CNS that modulates the threshold of IFN1 responses against viral infections
  • play a pivotal role in inflammatory processes through the activation of Toll-like receptor signaling and the NFKB1 pathway
  • might participate in B-cell maturation or oncogenic activation of aggressive B-cell lymphomas, both during and after germinal center stages
  • PELI1 is a key modulator of RIPK1 that differentially controls the activation of necroptosis and apoptosis
  • CELLULAR PROCESS
    PHYSIOLOGICAL PROCESS
    PATHWAY
    metabolism
    signaling
    a component
    INTERACTION
    DNA
    RNA
    small molecule
    protein
  • associate with and ubiquitinate proteins, including the interleukin-1 receptor associated kinase-1 (IRAK1)
  • IRAK1-binding region of PELI1, PELI2, PELI3 proteins consists largely of a previously unidentified forkhead-associated (FHA) domain
  • binds constitutively with IL1R and forms an lL1-induced complex with IRAK4-IRAK1-TRAF6
  • targeting of PELI1 by MIR21 could potentially provide the basis for a negative feedback cycle regulating NF-kappaB signaling
  • (IRAK)-interacting proteins that possess RING-like domains
  • IRF3-dependent gene
  • interacting with IKBKE/TBK1 (IKBKE/TBK1 mediate the activation of PELI1 E3 ligase activity, as well as inducing the transcription of its gene and protein expression in response to TLR3 and TLR4 agonists)
  • directly interacted with the oncoprotein B cell chronic lymphocytic leukemia (BCL6) and induced lysine 63-mediated BCL6 polyubiquitination
  • E3 ubiquitin ligase PELI1 is a negative regulator of IFN1 induction in microglia, innate immune cells of the central nervous system (CNS)
  • ubiquitination of RIPK1 by PELI1 promotes the formation of necrosome and execution of necroptosis
  • cell & other
    REGULATION
    activated by dephosphorylation of multiple sites (required to inactivate Pellino 1, which could be a device for prolonging Pellino's E3 ubiquitin ligase activity)
    IKBKE/TBK1 that mediate the activation of PELI1 E3 ligase activity, as well as inducing the transcription of its gene and protein expression in response to TLR3 and TLR4 agonists
    Other phosphorylated at multiple sites by IRAK1 and IRAK4 and activation can be achieved by phosphorylating any one of several sites or a combination of other sites
    post-translationally modified by small-ubiquitin-related modifier-1 (SUMO1)
    ASSOCIATED DISORDERS
    corresponding disease(s)
    Other morbid association(s)
    TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
    constitutional       loss of function
    deficiency of Pellino 1 (PELI1), an E3 ubiquitin ligase, blocked necroptosis
    Susceptibility
    Variant & Polymorphism
    Candidate gene
    Marker
    Therapy target
    SystemTypeDisorderPubmed
    cardiovascularaquiredheart failure
    target for treatment of cardiac fibrosis and heart failure
    ANIMAL & CELL MODELS